Barclays Takes More Conservative Tone on Tempur-Pedic (TPX); Cutting Price Target As Competitive Forces Change

May 7, 2012 1:20 PM EDT
Get Alerts TPX Hot Sheet
Price: $63.14 +0.73%

Rating Summary:
    6 Buy, 12 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade TPX Now!
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Tempur-Pedic (NYSE: TPX) price target lowered from $85 to $63.

Analyst, Jessics Schoen, said, "We are taking a more conservative stance on valuation for the following reasons: the intensifying competitive environment for specialty mattresses, uncertainty around potential cannibalization presented by the Simplicity launch, and tough compares as a result of very strong industry growth in the last year, particularly in the specialty segment."

For an analyst ratings summary and ratings history on Tempur-Pedic click here. For more ratings news on Tempur-Pedic click here.

Shares of Tempur-Pedic closed at $56.71 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities


Add Your Comment